Short description
ZYUS is a biopharmaceutical company that offers patients cannabinoid and other phyto-therapeutic medical solutions.
Description
ZYUS is a biopharmaceutical company that offers patients cannabinoids and other phytotherapeutic medical solutions. The company elevates cannabinoids as a medical solution to alleviate suffering in patients who are experiencing discomfort due to chronic disease, treatment side effects, or conditions related to aging. It aims is to shift the paradigm from the treatment of physical disease to caring for overall well-being, by accelerating the adoption of phytotherapeutics. The company uses science as a driver to establish phytotherapeutics as a standard of care for treating disease and managing the experience of it.
The company was founded in 2018 and is headquartered in Saskatoon, Saskatchewan.
Last funding
Noway Youcantaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Saskatoon, Saskatchewan, Canada, North America
Founded on
January 1, 2018
Exited on
June 19, 2023
Went public on
June 19, 2023
Stock symbol
ZYUS
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$1230 - 4560
Sign in for full access
Investors
Noaccessforu
Sign in for full access
Founders
Brent Zettl